Western blotting assay revealed elevated levels of the epithelial marker E‐cadherin protein and reduced levels of the mesenchymal markers vimentin and SNAL1 protein in USP22‐deficient melanoma cells (Figure 3G). This evidence concerns the gene USP22 and melanoma.